Business Context and Reporting Period
This Form 8-K Current Report was filed by cbdMD, Inc. on December 3, 2021, covering events occurring on December 1, 2021. The company is incorporated in North Carolina and trades on the NYSE American under the symbols YCBD and YCBD PR A. The filing primarily addresses the departure of a senior executive.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only specific financial figure disclosed relates to executive compensation:
- Separation Payment: An additional $7,500 paid to the departing Chief Revenue Officer, plus current salary for a 30-day transition period.
Material Changes
The material change reported is the resignation of John J. Wiesehan as Chief Revenue Officer and from all other capacities, effective December 1, 2021. His responsibilities have been assumed by current executive management and other personnel. The resignation was executed pursuant to Section 6(c) of his Employment Agreement dated July 22, 2021.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, outlook, or management commentary regarding future financial performance. The primary risk disclosed is the operational transition following the executive's departure, which the company states has been managed by existing leadership. The Separation Agreement includes standard non-disclosure and non-disparagement provisions and a release of claims by the departing officer.
Investor Verification Checklist
- Verify the impact of the Chief Revenue Officer's departure on sales operations and strategic initiatives.
- Review the full text of the Separation Agreement (Exhibit 10.1) for any additional terms not summarized in the 8-K.
- Confirm the identity of the executives assuming the former CRO's responsibilities.
- Check subsequent filings for any updates on the company's financial performance, as this 8-K does not provide current period financial results.